EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Pan‐Cancer Analysis of CLDN3 and Its Contribution to 5‐FU Resistance in Colorectal Cancer

Xi Zeng, Lu Zhang, Qing Chen, Yan Zeng, Guanglei Yang, Dan Feng, Bin Han iD

IET Systems Biology · 2026-01 · 20 (1)

DOI: 10.1049/syb2.70059 ↗

Kurz gefasst

Fachartikel in der Zeitschrift IET Systems Biology, online erschienen am 28.02.2026. Verfasst von Xi Zeng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Affiliated Hospital of North Sichuan Medical College, Nanchong, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Claudin-3, Fluorouracil, Drug Resistance, Neoplasm. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Nanchong City and School Cooperation Project, Affiliated Hospital of North Sichuan Medical College Plan Projects, Anti-infective Agent Creation Engineering Research Centre of Sichuan Province Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The expression patterns and potential regulatory correlates of CLDN3 in cancers remain insufficiently characterised, necessitating further investigation. We employed R software alongside bioinformatics platforms to analyse the aberrant expression of CLDN3. Experiments in vitro, including proliferation, wound healing, cell cycle progression and apoptosis assays, were conducted to evaluate the role of CLDN3 in CRC. Co‐immunoprecipitation (CO‐IP) and immunofluorescence analyses were conducted to investigate the interaction between CLDN3 and TRIM28. Western blotting was employed to evaluate the effect of TRIM28 on CLDN3 SUMOylation and protein stability. CLDN3 was found to be overexpressed in several cancers. Genomic alterations and promoter hypomethylation were identified as key contributors to CLDN3 dysregulation. Bioinformatic analysis suggests that CLDN3 is associated with tumour progression and poor prognosis by influencing pathways, it also contributes to immune dysregulation and chemo‐resistance mechanisms. Knockdown of CLDN3 in CRC cells decreased proliferation and migration. CLDN3 overexpression was shown to reduce the sensitivity to 5‐FU in CRC cells. CO‐IP and immunofluorescence confirmed a direct interaction between CLDN3 and TRIM28. Western blot analysis demonstrated that TRIM28 mediates CLDN3 SUMOylation and degradation. CLDN3 influences the growth and chemotherapy resistance of CRC cells, its interaction with TRIM28 makes the TRIM28/CLDN3 axis as a promising therapeutic target for CRC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsClaudin-3FluorouracilDrug Resistance, NeoplasmHumansCell Line, TumorGene Expression Regulation, NeoplasticCell Proliferation

Stichwörter der Autor:innen

CLDN3bioinformaticscancer

Substanzen

Claudin-3FluorouracilCLDN3 protein, human

Autor:innen und Institutionen

  • Department of Pharmacy, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.
  • Institute of Pharmacy, North Sichuan Medical College, Nanchong, China.
  • Department of Gastroenterology, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.
  • GCP Center/Institute of Drug Clinical Trials, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.
  • Anti-Infective Agent Creation Engineering Research Centre of Sichuan Province, Sichuan Industrial Institute of Antibiotics, School of Pharmacy, Chengdu University, Chengdu, China.
  • Biotechnology Innovation Drug Application and Transformation Key Laboratory of Sichuan Province, North Sichuan Medical College, Nanchong, China.

ORCID-Profile: Bin Han

Förderung

  • Nanchong City and School Cooperation Project
  • Affiliated Hospital of North Sichuan Medical College Plan Projects
  • Anti-infective Agent Creation Engineering Research Centre of Sichuan Province Fund

Zitieren

APA

Zeng, X., Zhang, L., Chen, Q., Zeng, Y., Yang, G., Feng, D., & Han, B. (2026). Pan‐Cancer Analysis of CLDN3 and Its Contribution to 5‐FU Resistance in Colorectal Cancer. IET Systems Biology, 20(1). https://doi.org/10.1049/syb2.70059

Vancouver

Zeng X, Zhang L, Chen Q, Zeng Y, Yang G, Feng D, et al. Pan‐Cancer Analysis of CLDN3 and Its Contribution to 5‐FU Resistance in Colorectal Cancer. IET Systems Biology. 2026;20(1). doi:10.1049/syb2.70059

BibTeX
@article{Zeng2026,
  author = {Zeng, Xi and Zhang, Lu and Chen, Qing and Zeng, Yan and Yang, Guanglei and Feng, Dan and Han, Bin},
  title = {Pan‐Cancer Analysis of CLDN3 and Its Contribution to 5‐FU Resistance in Colorectal Cancer},
  journal = {IET Systems Biology},
  year = {2026},
  volume = {20},
  number = {1},
  doi = {10.1049/syb2.70059}
}
Kostenlos starten →